<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(7)</volume><submitter>de Prisco N</submitter><pubmed_abstract>Alternative polyadenylation (APA) creates distinct transcripts from the same gene by cleaving the pre-mRNA at poly(A) sites that can lie within the 3' untranslated region (3'UTR), introns, or exons. Most studies focus on APA within the 3'UTR; however, here, we show that CPSF6 insufficiency alters protein levels and causes a developmental syndrome by deregulating APA throughout the transcript. In neonatal humans and zebrafish larvae, CPSF6 insufficiency shifts poly(A) site usage between the 3'UTR and internal sites in a pathway-specific manner. Genes associated with neuronal function undergo mostly intronic APA, reducing their expression, while genes associated with heart and skeletal function mostly undergo 3'UTR APA and are up-regulated. This suggests that, under healthy conditions, cells toggle between internal and 3'UTR APA to modulate protein expression.</pubmed_abstract><journal>Science advances</journal><pagination>eade4814</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9937581</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Alternative polyadenylation alters protein dosage by switching between intronic and 3'UTR sites.</pubmed_title><pmcid>PMC9937581</pmcid><pubmed_authors>Bi W</pubmed_authors><pubmed_authors>Jonnakuti VS</pubmed_authors><pubmed_authors>Prescott T</pubmed_authors><pubmed_authors>Huang KL</pubmed_authors><pubmed_authors>Rosenfeld JA</pubmed_authors><pubmed_authors>Tveten K</pubmed_authors><pubmed_authors>Nella AA</pubmed_authors><pubmed_authors>Chung WK</pubmed_authors><pubmed_authors>Targoff KL</pubmed_authors><pubmed_authors>Yalamanchili HK</pubmed_authors><pubmed_authors>Elrod ND</pubmed_authors><pubmed_authors>de Prisco N</pubmed_authors><pubmed_authors>Jovanovic M</pubmed_authors><pubmed_authors>Botta S</pubmed_authors><pubmed_authors>Gerstner T</pubmed_authors><pubmed_authors>Tang LC</pubmed_authors><pubmed_authors>Schroeder A</pubmed_authors><pubmed_authors>Cabaj M</pubmed_authors><pubmed_authors>George-Abraham JK</pubmed_authors><pubmed_authors>Wojcik MH</pubmed_authors><pubmed_authors>Wagner EJ</pubmed_authors><pubmed_authors>Reinson K</pubmed_authors><pubmed_authors>Gennarino VA</pubmed_authors><pubmed_authors>Ji P</pubmed_authors><pubmed_authors>Ounap K</pubmed_authors><pubmed_authors>Hanson-Khan A</pubmed_authors><pubmed_authors>Boyle L</pubmed_authors><pubmed_authors>Lin A</pubmed_authors><pubmed_authors>Fong CT</pubmed_authors><pubmed_authors>Brandt V</pubmed_authors><pubmed_authors>Ford C</pubmed_authors><pubmed_authors>Lee W</pubmed_authors><pubmed_authors>Bernstein JA</pubmed_authors><pubmed_authors>Buchanan CA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alternative polyadenylation alters protein dosage by switching between intronic and 3'UTR sites.</name><description>Alternative polyadenylation (APA) creates distinct transcripts from the same gene by cleaving the pre-mRNA at poly(A) sites that can lie within the 3' untranslated region (3'UTR), introns, or exons. Most studies focus on APA within the 3'UTR; however, here, we show that CPSF6 insufficiency alters protein levels and causes a developmental syndrome by deregulating APA throughout the transcript. In neonatal humans and zebrafish larvae, CPSF6 insufficiency shifts poly(A) site usage between the 3'UTR and internal sites in a pathway-specific manner. Genes associated with neuronal function undergo mostly intronic APA, reducing their expression, while genes associated with heart and skeletal function mostly undergo 3'UTR APA and are up-regulated. This suggests that, under healthy conditions, cells toggle between internal and 3'UTR APA to modulate protein expression.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2024-10-18T14:46:22.612Z</modification><creation>2024-10-18T14:46:22.612Z</creation></dates><accession>S-EPMC9937581</accession><cross_references><pubmed>36800428</pubmed><doi>10.1126/sciadv.ade4814</doi></cross_references></HashMap>